메뉴 건너뛰기




Volumn 71, Issue 9, 2012, Pages 1484-1489

Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis

Author keywords

[No Author keywords available]

Indexed keywords

METHIONINE SYNTHASE REDUCTASE; METHOTREXATE; MULTIDRUG RESISTANCE PROTEIN 1; PROTON COUPLED FOLATE TRANSPORTER;

EID: 84864882571     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-200942     Document Type: Article
Times cited : (61)

References (33)
  • 1
    • 33847287323 scopus 로고    scopus 로고
    • Juvenile idiopathic arthritis
    • Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet 2007;369:767-78.
    • (2007) Lancet , vol.369 , pp. 767-778
    • Ravelli, A.1    Martini, A.2
  • 2
    • 77950512831 scopus 로고    scopus 로고
    • Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: A randomized clinical trial
    • Foell D, Wulffraat N, Wedderburn LR, et al. Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA 2010;303:1266-73.
    • (2010) JAMA , vol.303 , pp. 1266-1273
    • Foell, D.1    Wulffraat, N.2    Wedderburn, L.R.3
  • 7
    • 78249256670 scopus 로고    scopus 로고
    • The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis
    • Swart JF, Barug D, Möhlmann M, et al. The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis. Expert Opin Biol Ther 2010;10:1743-52.
    • (2010) Expert Opin Biol Ther , vol.10 , pp. 1743-1752
    • Swart, J.F.1    Barug, D.2    Möhlmann, M.3
  • 8
    • 66149142293 scopus 로고    scopus 로고
    • Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: The Dutch national register
    • Prince FH, Twilt M, ten Cate R, et al. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register. Ann Rheum Dis 2009;68:635-41.
    • (2009) Ann Rheum Dis , vol.68 , pp. 635-641
    • Prince, F.H.1    Twilt, M.2    Ten Cate, R.3
  • 9
    • 70350449256 scopus 로고    scopus 로고
    • New advances in the management of juvenile idiopathic arthritis-2: The era of biologicals
    • Beresford MW, Baildam EM. New advances in the management of juvenile idiopathic arthritis-2: the era of biologicals. Arch Dis Child Educ Pract Ed 2009;94:151-6.
    • (2009) Arch Dis Child Educ Pract Ed , vol.94 , pp. 151-156
    • Beresford, M.W.1    Baildam, E.M.2
  • 10
    • 79955670864 scopus 로고    scopus 로고
    • Inhibition of IL6 in rheumatoid arthritis and juvenile idiopathic arthritis
    • Mircic M, Kavanaugh A. Inhibition of IL6 in rheumatoid arthritis and juvenile idiopathic arthritis. Exp Cell Res 2011;317:1286-92.
    • (2011) Exp Cell Res , vol.317 , pp. 1286-1292
    • Mircic, M.1    Kavanaugh, A.2
  • 11
    • 80051470174 scopus 로고    scopus 로고
    • Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): A multicentre randomised open-label clinical trial
    • Tynjälä P, Vähäsalo P, Tarkiainen M, et al. Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial. Ann Rheum Dis 2011;70:1605-12.
    • (2011) Ann Rheum Dis , vol.70 , pp. 1605-1612
    • Tynjälä, P.1    Vähäsalo, P.2    Tarkiainen, M.3
  • 12
    • 77957584399 scopus 로고    scopus 로고
    • The safety profile of biologic therapies for juvenile idiopathic arthritis
    • Hashkes PJ, Uziel Y, Laxer RM. The safety profile of biologic therapies for juvenile idiopathic arthritis. Nat Rev Rheumatol 2010;6:561-71.
    • (2010) Nat Rev Rheumatol , vol.6 , pp. 561-571
    • Hashkes, P.J.1    Uziel, Y.2    Laxer, R.M.3
  • 13
    • 77955738020 scopus 로고    scopus 로고
    • Occurrence of inflammatory bowel disease during treatment of juvenile idiopathic arthritis with etanercept: A French retrospective study
    • Dallocchio A, Canioni D, Ruemmele F, et al. Occurrence of inflammatory bowel disease during treatment of juvenile idiopathic arthritis with etanercept: a French retrospective study. Rheumatology (Oxford) 2010;49:1694-8.
    • (2010) Rheumatology (Oxford) , vol.49 , pp. 1694-1698
    • Dallocchio, A.1    Canioni, D.2    Ruemmele, F.3
  • 14
    • 77955371398 scopus 로고    scopus 로고
    • Tumor necrosis factor alpha blockers and malignancy in children: Forty-eight cases reported to the Food and Drug Administration
    • Diak P, Siegel J, La Grenade L, et al. Tumor necrosis factor alpha blockers and malignancy in children: forty-eight cases reported to the Food and Drug Administration. Arthritis Rheum 2010;62:2517-24.
    • (2010) Arthritis Rheum , vol.62 , pp. 2517-2524
    • Diak, P.1    Siegel, J.2    La Grenade, L.3
  • 15
    • 65249098979 scopus 로고    scopus 로고
    • Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): Preliminary data from the German JIA Registry
    • Horneff G, De Bock F, Foeldvari I, et al. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry. Ann Rheum Dis 2009;68:519-25.
    • (2009) Ann Rheum Dis , vol.68 , pp. 519-525
    • Horneff, G.1    De Bock, F.2    Foeldvari, I.3
  • 16
    • 78650990577 scopus 로고    scopus 로고
    • Pediatric rheumatology: JIA, treatment and possible risk of malignancies
    • Ruperto N, Martini A. Pediatric rheumatology: JIA, treatment and possible risk of malignancies. Nat Rev Rheumatol 2011;7:6-7.
    • (2011) Nat Rev Rheumatol , vol.7 , pp. 6-7
    • Ruperto, N.1    Martini, A.2
  • 21
    • 0035404474 scopus 로고    scopus 로고
    • The Dutch version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ)
    • Wulffraat N, van der Net JJ, Ruperto N, et al. The Dutch version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol 2001;19(4 Suppl 23):S111-5.
    • (2001) Clin Exp Rheumatol , vol.19 , Issue.4 SUPPL. 23
    • Wulffraat, N.1    Van Der Net, J.J.2    Ruperto, N.3
  • 22
    • 77953495664 scopus 로고    scopus 로고
    • Do snapshot statistics fool us in MTX pharmacogenetic studies in arthritis research?
    • de Rotte MC, Luime JJ, Bulatovic M, et al. Do snapshot statistics fool us in MTX pharmacogenetic studies in arthritis research? Rheumatology (Oxford) 2010;49:1200-1.
    • (2010) Rheumatology (Oxford) , vol.49 , pp. 1200-1201
    • De Rotte, M.C.1    Luime, J.J.2    Bulatovic, M.3
  • 23
    • 58349116270 scopus 로고    scopus 로고
    • Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis
    • Albers HM, Wessels JA, van der Straaten RJ, et al. Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis. Arthritis Rheum 2009;61:46-51.
    • (2009) Arthritis Rheum , vol.61 , pp. 46-51
    • Albers, H.M.1    Wessels, J.A.2    Van Der Straaten, R.J.3
  • 24
    • 77955450480 scopus 로고    scopus 로고
    • Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: Analysis of the PRINTO methotrexate trial
    • Vilca I, Munitis PG, Pistorio A, et al. Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial. Ann Rheum Dis 2010;69:1479-83.
    • (2010) Ann Rheum Dis , vol.69 , pp. 1479-1483
    • Vilca, I.1    Munitis, P.G.2    Pistorio, A.3
  • 25
    • 0033503925 scopus 로고    scopus 로고
    • The extended oligoarticular subtype is the best predictor of methotrexate efficacy in juvenile idiopathic arthritis
    • Ravelli A, Viola S, Migliavacca D, et al. The extended oligoarticular subtype is the best predictor of methotrexate efficacy in juvenile idiopathic arthritis. J Pediatr 1999;135:316-20. (Pubitemid 30180504)
    • (1999) Journal of Pediatrics , vol.135 , Issue.3 , pp. 316-320
    • Ravelli, A.1    Viola, S.2    Migliavacca, D.3    Ruperto, N.4    Pistorio, A.5    Martini, A.6
  • 26
    • 0033875824 scopus 로고    scopus 로고
    • Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis
    • Woo P, Southwood TR, Prieur AM, et al. Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. Arthritis Rheum 2000;43:1849-57.
    • (2000) Arthritis Rheum , vol.43 , pp. 1849-1857
    • Woo, P.1    Southwood, T.R.2    Prieur, A.M.3
  • 27
    • 0026609159 scopus 로고
    • Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial
    • The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group
    • Giannini EH, Brewer EJ, Kuzmina N, et al. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group. N Engl J Med 1992;326:1043-9.
    • (1992) N Engl J Med , vol.326 , pp. 1043-1049
    • Giannini, E.H.1    Brewer, E.J.2    Kuzmina, N.3
  • 30
    • 75749134134 scopus 로고    scopus 로고
    • Clinical course and prognostic value of disease activity in the first two years in different subtypes of juvenile idiopathic arthritis
    • Albers HM, Brinkman DM, Kamphuis SS, et al. Clinical course and prognostic value of disease activity in the first two years in different subtypes of juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 2010;62:204-12.
    • (2010) Arthritis Care Res (Hoboken) , vol.62 , pp. 204-212
    • Albers, H.M.1    Brinkman, D.M.2    Kamphuis, S.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.